Literature DB >> 34127678

The progression of disorder-specific brain pattern expression in schizophrenia over 9 years.

Dominic B Dwyer1, Nikolaos Koutsouleris1,2,3, Johannes Lieslehto4,5,6, Erika Jääskeläinen7,8,9, Vesa Kiviniemi9,10, Marianne Haapea7,8,9, Peter B Jones11, Graham K Murray11, Juha Veijola8,9,12, Udo Dannlowski13, Dominik Grotegerd13, Susanne Meinert13, Tim Hahn13, Anne Ruef1, Matti Isohanni7, Peter Falkai1, Jouko Miettunen7,9.   

Abstract

Age plays a crucial role in the performance of schizophrenia vs. controls (SZ-HC) neuroimaging-based machine learning (ML) models as the accuracy of identifying first-episode psychosis from controls is poor compared to chronic patients. Resolving whether this finding reflects longitudinal progression in a disorder-specific brain pattern or a systematic but non-disorder-specific deviation from a normal brain aging (BA) trajectory in schizophrenia would help the clinical translation of diagnostic ML models. We trained two ML models on structural MRI data: an SZ-HC model based on 70 schizophrenia patients and 74 controls and a BA model (based on 561 healthy individuals, age range = 66 years). We then investigated the two models' predictions in the naturalistic longitudinal Northern Finland Birth Cohort 1966 (NFBC1966) following 29 schizophrenia and 61 controls for nine years. The SZ-HC model's schizophrenia-specificity was further assessed by utilizing independent validation (62 schizophrenia, 95 controls) and depression samples (203 depression, 203 controls). We found better performance at the NFBC1966 follow-up (sensitivity = 75.9%, specificity = 83.6%) compared to the baseline (sensitivity = 58.6%, specificity = 86.9%). This finding resulted from progression in disorder-specific pattern expression in schizophrenia and was not explained by concomitant acceleration of brain aging. The disorder-specific pattern's progression reflected longitudinal changes in cognition, outcomes, and local brain changes, while BA captured treatment-related and global brain alterations. The SZ-HC model was also generalizable to independent schizophrenia validation samples but classified depression as control subjects. Our research underlines the importance of taking account of longitudinal progression in a disorder-specific pattern in schizophrenia when developing ML classifiers for different age groups.

Entities:  

Year:  2021        PMID: 34127678     DOI: 10.1038/s41537-021-00157-0

Source DB:  PubMed          Journal:  NPJ Schizophr        ISSN: 2334-265X


  51 in total

1.  Progressive ventricular expansion in chronic poor-outcome schizophrenia.

Authors:  Serge A Mitelman; Emily L Canfield; Adam M Brickman; Lina Shihabuddin; Erin A Hazlett; Monte S Buchsbaum
Journal:  Cogn Behav Neurol       Date:  2010-06       Impact factor: 1.600

2.  Focal gray matter changes in schizophrenia across the course of the illness: a 5-year follow-up study.

Authors:  Neeltje E M van Haren; Hilleke E Hulshoff Pol; Hugo G Schnack; Wiepke Cahn; René C W Mandl; D Louis Collins; Alan C Evans; René S Kahn
Journal:  Neuropsychopharmacology       Date:  2007-02-28       Impact factor: 7.853

Review 3.  A systematic review and meta-analysis of recovery in schizophrenia.

Authors:  Erika Jääskeläinen; Pauliina Juola; Noora Hirvonen; John J McGrath; Sukanta Saha; Matti Isohanni; Juha Veijola; Jouko Miettunen
Journal:  Schizophr Bull       Date:  2012-11-20       Impact factor: 9.306

Review 4.  Machine Learning Approaches for Clinical Psychology and Psychiatry.

Authors:  Dominic B Dwyer; Peter Falkai; Nikolaos Koutsouleris
Journal:  Annu Rev Clin Psychol       Date:  2018-01-29       Impact factor: 18.561

5.  Detecting neuroimaging biomarkers for schizophrenia: a meta-analysis of multivariate pattern recognition studies.

Authors:  Joseph Kambeitz; Lana Kambeitz-Ilankovic; Stefan Leucht; Stephen Wood; Christos Davatzikos; Berend Malchow; Peter Falkai; Nikolaos Koutsouleris
Journal:  Neuropsychopharmacology       Date:  2015-01-20       Impact factor: 7.853

6.  Ventricular enlargement in poor-outcome schizophrenia.

Authors:  K L Davis; M S Buchsbaum; L Shihabuddin; J Spiegel-Cohen; M Metzger; E Frecska; R S Keefe; P Powchik
Journal:  Biol Psychiatry       Date:  1998-06-01       Impact factor: 13.382

7.  Associations between crestal lamina dura and periodontal status.

Authors:  G Greenstein; A Polson; H Iker; S Meitner
Journal:  J Periodontol       Date:  1981-07       Impact factor: 6.993

Review 8.  The myth of schizophrenia as a progressive brain disease.

Authors:  Robert B Zipursky; Thomas J Reilly; Robin M Murray
Journal:  Schizophr Bull       Date:  2012-11-20       Impact factor: 9.306

9.  Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies.

Authors:  P Fusar-Poli; R Smieskova; M J Kempton; B C Ho; N C Andreasen; S Borgwardt
Journal:  Neurosci Biobehav Rev       Date:  2013-06-14       Impact factor: 8.989

10.  Longitudinal changes in total brain volume in schizophrenia: relation to symptom severity, cognition and antipsychotic medication.

Authors:  Juha Veijola; Joyce Y Guo; Jani S Moilanen; Erika Jääskeläinen; Jouko Miettunen; Merja Kyllönen; Marianne Haapea; Sanna Huhtaniska; Antti Alaräisänen; Pirjo Mäki; Vesa Kiviniemi; Juha Nikkinen; Tuomo Starck; Jukka J Remes; Päivikki Tanskanen; Osmo Tervonen; Alle-Meije Wink; Angie Kehagia; John Suckling; Hiroyuki Kobayashi; Jennifer H Barnett; Anna Barnes; Hannu J Koponen; Peter B Jones; Matti Isohanni; Graham K Murray
Journal:  PLoS One       Date:  2014-07-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.